TELCON RF PHARMACEUTICAL. Statistics

Total Valuation

KOSDAQ:200230 has a market cap or net worth of KRW 36.15 billion. The enterprise value is 30.13 billion.

Market Cap	36.15B
Enterprise Value	30.13B

Important Dates

The next estimated earnings date is Thursday, March 19, 2026.

Earnings Date	Mar 19, 2026
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:200230 has 36.05 million shares outstanding. The number of shares has increased by 140.22% in one year.

Current Share Class	36.05M
Shares Outstanding	36.05M
Shares Change (YoY)	+140.22%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	n/a
Float	23.86M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.83
PB Ratio	0.35
P/TBV Ratio	0.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.90
EV / Sales	0.69
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-25.38

Financial Position

The company has a current ratio of 1.00, with a Debt / Equity ratio of 0.33.

Current Ratio	1.00
Quick Ratio	0.87
Debt / Equity	0.33
Debt / EBITDA	5.81
Debt / FCF	-28.68
Interest Coverage	0.22

Financial Efficiency

Return on equity (ROE) is -33.90% and return on invested capital (ROIC) is 0.56%.

Return on Equity (ROE)	-33.90%
Return on Assets (ROA)	0.50%
Return on Invested Capital (ROIC)	0.56%
Return on Capital Employed (ROCE)	1.18%
Revenue Per Employee	346.65M
Profits Per Employee	-265.91M
Employee Count	126
Asset Turnover	0.28
Inventory Turnover	6.22

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -45.19% in the last 52 weeks. The beta is 0.87, so KOSDAQ:200230's price volatility has been lower than the market average.

Beta (5Y)	0.87
52-Week Price Change	-45.19%
50-Day Moving Average	1,074.58
200-Day Moving Average	1,448.78
Relative Strength Index (RSI)	45.84
Average Volume (20 Days)	1,791,631

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:200230 had revenue of KRW 43.68 billion and -33.51 billion in losses. Loss per share was -806.02.

Revenue	43.68B
Gross Profit	11.64B
Operating Income	1.23B
Pretax Income	-33.48B
Net Income	-33.51B
EBITDA	5.86B
EBIT	1.23B
Loss Per Share	-806.02

Full Income Statement

Balance Sheet

The company has 40.38 billion in cash and 34.04 billion in debt, giving a net cash position of 6.34 billion or 175.99 per share.

Cash & Cash Equivalents	40.38B
Total Debt	34.04B
Net Cash	6.34B
Net Cash Per Share	175.99
Equity (Book Value)	102.01B
Book Value Per Share	2,873.29
Working Capital	-113.23M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -155.38 million and capital expenditures -1.03 billion, giving a free cash flow of -1.19 billion.

Operating Cash Flow	-155.38M
Capital Expenditures	-1.03B
Free Cash Flow	-1.19B
FCF Per Share	-32.93

Full Cash Flow Statement

Margins

Gross margin is 26.65%, with operating and profit margins of 2.81% and -76.71%.

Gross Margin	26.65%
Operating Margin	2.81%
Pretax Margin	-76.66%
Profit Margin	-76.71%
EBITDA Margin	13.41%
EBIT Margin	2.81%
FCF Margin	n/a

Dividends & Yields

KOSDAQ:200230 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-140.22%
Shareholder Yield	-140.22%
Earnings Yield	-92.67%
FCF Yield	-3.28%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 22, 2025. It was a forward split with a ratio of 3.

Last Split Date	Aug 22, 2025
Split Type	Forward
Split Ratio	3

Scores

KOSDAQ:200230 has an Altman Z-Score of -0.85 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.85
Piotroski F-Score	5